Surveillance of gonococcal antimicrobial susceptibility resulting in early detection of emerging resistance
Open Access
- 14 February 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 67 (6) , 1422-1426
Abstract
To undertake laboratory and clinical surveillance of gonococcal antimicrobial susceptibility to various therapeutic agents in Hong Kong, so as to monitor for emerging resistance and to inform on appropriate choice of empirical therapy. Trends in susceptibility of gonococci to ceftriaxone, spectinomycin, ceftibuten and azithromycin were monitored over time. Isolates with reduced susceptibility to oral extended-spectrum cephalosporins were further characterized by detection of the mosaic penA gene and typing by Neisseria gonorrhoeae multi-antigen sequence typing (NG-MAST). Correlation with clinical and epidemiological findings was undertaken on isolates positive for the mosaic penA gene. Trends in susceptibility of gonococci to ceftriaxone, spectinomycin and ceftibuten remained stable between 2005 and 2010. In 2010, 30.3% of tested strains were not susceptible to azithromycin. The percentage of gonococcal strains harbouring the mosaic penA gene increased from 1.0% during April to December 2010 to 8.2% during January to September 2011 (P < 0.0001). Review of available clinical records showed that, out of 35 patients infected by strains positive for the mosaic penA gene, 30 had laboratory-documented treatment failure. This study showed that ceftriaxone and spectinomycin remained effective against gonorrhoea in Hong Kong. There was an alarming increase in strains with reduced susceptibility to oral extended-spectrum cephalosporins associated with clinical treatment failure. One-third of gonococcal isolates were non-susceptible to azithromycin. The need to switch to agents other than oral extended-spectrum cephalosporins for empirical treatment is imminent. Continued surveillance with strain characterization is essential to monitor the effectiveness of currently recommended therapy.Keywords
This publication has 17 references indexed in Scilit:
- Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to CeftriaxoneAntimicrobial Agents and Chemotherapy, 2011
- 2009 European (IUSTI/WHO) Guideline on the Diagnosis and Treatment of Gonorrhoea in AdultsInternational Journal of STD & AIDS, 2009
- Evaluation of replacing the existing diagnostic strategy for Neisseria gonorrhoeae and Chlamydia trachomatis infections with sole molecular testing of urine specimens in a sexually transmitted infection clinic settingSexually Transmitted Infections, 2009
- Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposesJournal of Antimicrobial Chemotherapy, 2009
- Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporinsCurrent Opinion in Infectious Diseases, 2009
- Ceftibuten Resistance and Treatment Failure ofNeisseria gonorrhoeaeInfectionAntimicrobial Agents and Chemotherapy, 2008
- Antibiotic Resistance inNeisseria gonorrhoeaeClinical Infectious Diseases, 2005
- Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h intervalJournal of Infection and Chemotherapy, 2003
- Mosaic-Like Structure of Penicillin-Binding Protein 2 Gene ( penA ) in Clinical Isolates of Neisseria gonorrhoeae with Reduced Susceptibility to CefiximeAntimicrobial Agents and Chemotherapy, 2002
- Clinical Evaluation of Ceftibuten in GonorrheaSexually Transmitted Diseases, 1998